Literature DB >> 14208504

CHARACTERIZATION OF THE PYROGENICITY OF CANDIDA ALBICANS, SACCHAROMYCES CEREVISIAE, AND CRYPTOCOCCUS NEOFORMANS.

G S KOBAYASHI, L FRIEDMAN.   

Abstract

Kobayashi, George S. (Tulane University, New Orleans, La.), and Lorraine Friedman. Characterization of the pyrogenicity of Candida albicans, Saccharomyces cerevisiae, and Cryptococcus neoformans. J. Bacteriol. 88:660-666. 1964.-The intravenous injection into rabbits of 10(9) yeast cells of Candida albicans, Saccharomyces cerevisiae, or Cryptococcus neoformans (both slightly and heavily encapsulated forms) induced a febrile response indistinguishable from that elicited by gram-negative bacterial endotoxin. There was a brisk rise in body temperature which began as early as 30 min after injection, peaked once or twice, and then returned to normal after about 10 hr. With viable C. albicans, the febrile response did not return to normal but remained elevated for several days and terminated at death of the animal. Of three extraction procedures employed in attempts to isolate the endotoxin-like pyrogenically active substances from C. albicans, only one, the phenol extraction method, was successful. Pyrogenic substances were more easily extractable from S. cerevisiae, but extracted cells of both species were still highly pyrogenic. It was concluded that the particulate nature of the yeast cell did not contribute to the induction of fever, for latex particles of a similar size were nonpyrogenic. Viable or heat-killed C. albicans, phenol extract of C. albicans, zymosan, and polystyrene latex particles all failed to induce in rabbits increased dermal reactivity to epinephrine.

Entities:  

Keywords:  BODY TEMPERATURE; CANDIDA; CRYPTOCOCCUS; ENDOTOXINS; EPINEPHRINE; ESCHERICHIA COLI; EXPERIMENTAL LAB STUDY; FEVER; PHARMACOLOGY; POLYSTYRENES; PYROGENS; RABBITS; SACCHAROMYCES; ZYMOSAN

Mesh:

Substances:

Year:  1964        PMID: 14208504      PMCID: PMC277363          DOI: 10.1128/jb.88.3.660-666.1964

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  23 in total

1.  [Antigens common to the Candida and Salmonella-Arizona].

Authors:  N AKSOYCAN; L LE MINOR; S LE MINOR
Journal:  Ann Inst Pasteur (Paris)       Date:  1960-11

2.  The effects of staphylococcal extract and of viable staphylococci on dermal reactivity of the rabbit to epinephrine.

Authors:  E NETER; H ANZAI; E A GORZYNSKI
Journal:  J Infect Dis       Date:  1960 Nov-Dec       Impact factor: 5.226

3.  Endotoxic and antigenic fractions from the cell wall of Salmonella enteritidis; methods for separation and some biologic activities.

Authors:  E RIBI; K C MILNER; T D PERRINE
Journal:  J Immunol       Date:  1959-01       Impact factor: 5.422

4.  Observations on the pyrogenic response and its application to the bioassay of endotoxin.

Authors:  W R KEENE; H R SILBERMAN; M LANDY
Journal:  J Clin Invest       Date:  1961-02       Impact factor: 14.808

5.  Fever from pathogenic fungi.

Authors:  A I BRAUDE; J McCONNELL; H DOUGLAS
Journal:  J Clin Invest       Date:  1960-08       Impact factor: 14.808

6.  Moniliasis in pediatrics.

Authors:  B DOBIAS
Journal:  AMA J Dis Child       Date:  1957-09

7.  The cytotoxic action in vitro and in vivo of lipid-containing and lipid-free proteose; the toxicity of protein hydrolysate of Saccharomyces cerevisiae.

Authors:  H LUND
Journal:  Acta Pathol Microbiol Scand       Date:  1953

8.  The biology of experimental human cutaneous moniliasis (Candida albicans).

Authors:  H I MAIBACH; A M KLIGMAN
Journal:  Arch Dermatol       Date:  1962-02

9.  SOME CYTOLOGICAL AND PATHOGENIC PROPERTIES OF SPHEROPLASTS OF CANDIDA ALBICANS.

Authors:  G S KOBAYASHI; L FRIEDMAN; J F KOFROTH
Journal:  J Bacteriol       Date:  1964-09       Impact factor: 3.490

10.  The role of epinephrine in the reactions produced by the endotoxins of gram-negative bacteria. I. Hemorrhagic necrosis produced by epinephrine in the skin of endotoxin-treated rabbits.

Authors:  L THOMAS
Journal:  J Exp Med       Date:  1956-12-01       Impact factor: 14.307

View more
  12 in total

1.  Highly sensitive pyrogen detection on medical devices by the monocyte activation test.

Authors:  Katharina Stang; Stefan Fennrich; Stefanie Krajewski; Sandra Stoppelkamp; Iwan Anton Burgener; Hans-Peter Wendel; Marcell Post
Journal:  J Mater Sci Mater Med       Date:  2014-01-12       Impact factor: 3.896

2.  Pyrogenic principle of the ribonucleic acid from the yeast Candida utilis.

Authors:  S Kanoh; H Kohlhage; R Siegert
Journal:  J Bacteriol       Date:  1968-09       Impact factor: 3.490

3.  Endotoxic substance of Cryptococcus neoformans.

Authors:  T Kobayashi; I Nakashima; N Kato
Journal:  Mycopathol Mycol Appl       Date:  1974-11-29

4.  Polymorphonuclear leukocyte chemotaxis in sporotrichosis.

Authors:  H Hachisuka; S Tajiri; K Hongo; Y Sasai
Journal:  Mycopathologia       Date:  1982-07-23       Impact factor: 2.574

5.  Systemic candidiasis in mice treated with prednisolone and amphotericin B. 2. Ultrastructure and evidence for fungal toxin.

Authors:  W Blyth; G E Stewart
Journal:  Mycopathologia       Date:  1978-12-29       Impact factor: 2.574

6.  Fungal toxins as a parasitic factor responsible for the establishment of fungal infections.

Authors:  K Iwata
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

7.  Effect in mice of injection of viable Candida albicans and a cell-free sonic extract on circulating platelets.

Authors:  I A Holder; P Nathan
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

8.  Assessment of pyrogenic contaminations with validated human whole-blood assay.

Authors:  Mardas Daneshian; Sonja von Aulock; Thomas Hartung
Journal:  Nat Protoc       Date:  2009-11-05       Impact factor: 13.491

9.  Physiological and metabolic alterations accompanying systemic candidiasis in mice.

Authors:  R D Leunk; R J Moon
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

10.  Role of complement during experimental Candida infection in mice.

Authors:  R Morelli; L T Rosenberg
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.